TREM2 and Alzheimer disease: Proteolytic processing cleaves the ectodomain of TREM2 and releases it as a soluble fragment (sTREM2) with pro-inflammatory actions [177] that can be detected in the CSF and serum of patients (elevated in AD) [178].